Mayo Clinic
This is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molecular tests for patients with renal cell carcinoma (RCC). Aim 1 will use urine collected previously in biorepository. Aim 2 will prospectively collect blood specimens pre and post nephrectomy.
Inclusion Criteria: * Urine sample in existing biorepository * High-risk renal cell carcinoma (RCC) per American Urological Association (AUA) guidelines * Scheduled to undergo nephrectomy Exclusion Criteria: * Does not meet inclusion criteria
EV isolation and mass spectrometry.
Blood samples collected pre- and post-nephrectomy
Verify or correct the compensation shown for this listing.